Colgate-Palmolive Company (CL) earnings on October 30, 2026
More Colgate-Palmolive Company earnings
Prior outlook: No statistical edge
Volatly's outlook before the earnings on October 30, 2026: No statistical edge.
CL price around the earnings
There is no candle series available for this event.
Prior thesis
Prior outlook: No statistical edge
- Thesis published
- Results released
Stronger setup supports cautious optimistic outlook
The price setup is the stronger force, reinforced by analyst growth expectations, positively surprising recent results, and an average price target above the current price. The data show that more cautious crowd positioning and a class-action lawsuit create risk, but the stronger setup still prevails.
Context analyzed before publication
- Summary
- Stronger setup supports cautious optimistic outlook
- Playbook
- Price has advanced 7.1% over 32 days and now sits near $92.65 resistance, while analyst targets average $98. The data show constraints from a pending class-action notice and overly optimistic crowd expectations.
- Trend
- Expert optimism improved sharply, then eased slightly
Analysts
Drivers
-
Analysts
Positive
The average analyst price target is $98, about 6.5% above the current price. JP Morgan and Piper Sandler recently raised their ratings to positive.
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 2.1
- Analysts covering the stock
- 20
- Average price target
- 98.15
- Lowest price target
- 87
- Highest price target
- 110
- Upside to price target
- 6.5%
- Quarterly earnings growth
- -6.7%
- Revenue growth
- 4.9%
- Forward EPS
- 4.09
- Trailing EPS
- 2.54
- Analyst moves in the last 60 days
- 4
- Strong buy: 6
- Buy: 7
- Hold: 7
- Sell: 0
- Strong sell: 1
- Strong buy
- 6
- Buy
- 7
- Hold
- 7
- Sell
- 0
- Strong sell
- 1
- October 19, 2026 · JP Morgan: Maintains rating (Overweight → Overweight)
- October 5, 2026 · Wells Fargo: Maintains rating (Equal-Weight → Equal-Weight)
- September 21, 2026 · Piper Sandler: Maintains rating (Overweight → Overweight)
- September 8, 2026 · RBC Capital: Reiterates rating (Outperform → Outperform)
News and sentiment
Drivers
-
News & sentiment
Negative
A class-action lawsuit notice creates a direct legal risk for the company, but the overall scenario remains optimistic.
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- High
- Normalized volume
- 99%
- Messages
- 30
News
Sources (7)
- Notice of Class Action Lawsuit Regarding Recyclable Toothpaste Tubes (opens in a new tab) — fiscal.ai
- Colgate-Palmolive Named Non-Food Supplier of the Year by Coles (opens in a new tab) — fiscal.ai
- Colgate-Palmolive Expected to Post In-Line Q3 Results, UBS Says (opens in a new tab) — fiscal.ai
- Colgate-Palmolive Discusses TRUE v2 Sustainability Enhancements (opens in a new tab) — fiscal.ai
- JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $104 (opens in a new tab) — Benzinga
- JPMorgan Adjusts Price Target on Colgate-Palmolive to $104 From $103 (opens in a new tab) — fiscal.ai
- Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $90 (opens in a new tab) — Benzinga
Technicals
Drivers
-
Technical
Negative
The price rose 7.1% over 32 days and is now near $92.65 resistance. The $92.65 level marks the nearby resistance.
Evidence
- Price when the context was analyzed
- 92.2
- Average true range (ATR)
- 2.1%
- Distance to 52-week high
- -5.4%
- 14-day change (14d)
- +2.5%
- 30-day change (32d)
- +7.1%
- 30-day relative strength
- +7.3%
- SPY change (32d)
- -0.2%
- Nearest support
- 92.01
- Distance to nearest support
- 0.2%
- Nearest resistance
- 92.65
- Distance to nearest resistance
- 0.5%
- Volume accumulation ratio (14d / 46d)
- 1.19
- Mid: 92 (0.2% away, 0.1 ATR, 10 touches)
- Major: 91.45 (0.8% away, 0.38 ATR, 74 touches)
- Major: 90.65 (1.7% away, 0.79 ATR, 64 touches)
- Major: 92.65 (0.5% away, 0.23 ATR, 59 touches)
- Major: 93.5 (1.4% away, 0.66 ATR, 55 touches)
- Major: 94.23 (2.2% away, 1.03 ATR, 39 touches)
Trends
Evidence
- Average earnings surprise
- +3.4%
- July 31, 2026: actual EPS 0.99 vs estimate 0.95 (surprise +4.5%)
- May 1, 2026: actual EPS 0.97 vs estimate 0.94 (surprise +2.7%)
- January 30, 2026: actual EPS 0.95 vs estimate 0.91 (surprise +4.2%)
- October 31, 2025: actual EPS 0.91 vs estimate 0.89 (surprise +2.4%)
Expected move
Drivers
-
Past earnings
Positive
Recent earnings have consistently beaten analyst estimates, and the price has reacted positively after those reports.
- Implied move
- +4.0%
- Source
- Options chain
Reactions over its last 21 earnings
- Median move
- 2%
- 75th percentile move
- 4.2%
- 90th percentile move
- 5%
- Up / down moves
- 10 / 11
- Average up move
- +2.2%
- Average down move
- -2.7%
Monitoring and close
What Colgate-Palmolive Company reported
- Status
- Finished
| Actual EPS | 0.97 |
|---|---|
| EPS estimate | 0.93 |
| EPS surprise | +4.3% |
| Revenue | $5,369 million |
| Revenue estimate | $5,334 million |
| Revenue surprise | +0.7% |
Colgate-Palmolive beat third-quarter 2026 earnings estimates and raised its profitability outlook. The earnings-call transcript included Claire Ross, executive vice president of investor relations.
Sources (16)
- Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains (opens in a new tab) — Yahoo
- Colgate-Palmolive Lifts Full-Year Earnings Growth Outlook Following Third-Quarter Beat (opens in a new tab) — Yahoo
- Colgate-Palmolive Beats Q3 Estimates, Raises Profit Outlook Despite Weak US Demand, Rising Costs (opens in a new tab) — Benzinga
- Colgate-Palmolive Q3 2026 Earnings Call Transcript (opens in a new tab) — Benzinga
- S&P 500 Premarket Gainers and Losers on Oct. 30, 2026 (opens in a new tab) — ChartMill
- Colgate-Palmolive Company (CL) Q3 2026 Earnings Call Transcript (opens in a new tab) — SeekingAlpha
- Colgate-Palmolive (NYSE:CL) posts better-than-expected sales in Q3 2026, stock soars (opens in a new tab) — Yahoo
- Colgate-Palmolive (CL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (opens in a new tab) — Yahoo
- Colgate-Palmolive (NYSE:CL) Jumps as Margin Gains and Raised EPS Outlook Offset Revenue Miss (opens in a new tab) — ChartMill
- Colgate-Palmolive net sales top estimates despite "volatile" operating backdrop (opens in a new tab) — Yahoo
- Colgate-Palmolive (CL) Surpasses Q3 Earnings and Revenue Estimates (opens in a new tab) — Yahoo
- Colgate-Palmolive: Q3 Earnings Snapshot (opens in a new tab) — Yahoo
- Colgate-Palmolive Narrows FY2026 Sales Guidance from $20.790B-$21.605B to $21.197B-$21.401B vs $21.406B Est (opens in a new tab) — Benzinga
- Colgate-Palmolive reported adjusted EPS of $0.97, above the $0.93 estimate, and sales of $5.369 billion, above the $5.334 billion estimate. — Benzinga
- Colgate-Palmolive Q3 Adj. EPS $0.97 Beats $0.93 Estimate, Sales $5.369B Beat $5.334B Estimate (opens in a new tab) — Benzinga
- Colgate-Palmolive Announces 3rd Quarter 2026 Results (opens in a new tab) — Yahoo
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, Results beat expectations on both earnings and revenue and the price is indicating +5.0% pre-market, a move 3x the stock's usual reaction (about 2%). The figures don't confirm the prior scenario: there was no prior directional scenario to check against.